Cargando…

Serum metabolome alterations in patients with early nonalcoholic fatty liver disease

Background: Although metabolomic analysis for patients with nonalcoholic fatty liver disease (NAFLD) was a promising approach to identify novel biomarkers as targets for the diagnosis of NAFLD, the serum metabolomics profile of early-stage NAFLD patients from central China remain unknown. Objective:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuemei, Rao, Benchen, Wang, Haiyu, Liu, Chao, Ren, Zhigang, Yu, Zujiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583763/ https://www.ncbi.nlm.nih.gov/pubmed/36124945 http://dx.doi.org/10.1042/BSR20220319

Ejemplares similares

Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus
por: Xu, Linxin, et al.
Publicado: (2019)

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
por: Zou, Yawen, et al.
Publicado: (2023)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Alterations of the oral and gut mycobiome and cytokines during long-term follow-up of COVID-19 convalescents
por: Ren, Zhigang, et al.
Publicado: (2023)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation
por: Yang, Rong, et al.
Publicado: (2022)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Serum metabolomics analysis reveals metabolite profile and key biomarkers of idiopathic membranous nephropathy
por: Ye, Mingjun, et al.
Publicado: (2023)

Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease
por: Li, Jia, et al.
Publicado: (2019)

Using bioinformatics and metabolomics to identify altered granulosa cells in patients with diminished ovarian reserve
por: He, Ruifen, et al.
Publicado: (2020)

Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
por: Wei, Zihan, et al.
Publicado: (2019)

Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma
por: Zheng, Shaopeng, et al.
Publicado: (2021)

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
por: Tokushige, Katsutoshi, et al.
Publicado: (2013)

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
por: Gitto, Stefano, et al.
Publicado: (2018)

Recent advances in nonalcoholic fatty liver disease metabolomics
por: Kim, Hwi Young
Publicado: (2021)

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
por: Ren, Zhigang, et al.
Publicado: (2021)

Serum proteins differentially expressed in early- and late-onset preeclampsia assessed using iTRAQ proteomics and bioinformatics analyses
por: Tu, Chengcheng, et al.
Publicado: (2020)

Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island
por: Li, Bingxia, et al.
Publicado: (2023)

METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner
por: Tang, Jinhong, et al.
Publicado: (2022)

Compositional distinction of gut microbiota between Han Chinese and Tibetan populations with liver cirrhosis
por: Huan, Hui, et al.
Publicado: (2021)

Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure
por: Ren, Wei, et al.
Publicado: (2020)

HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels
por: Chen, Changxi, et al.
Publicado: (2020)

Metabolome and transcriptome analyses identify the characteristics and expression of related saponins of the three genealogical plants of bead ginseng
por: Ye, Yihan, et al.
Publicado: (2023)

Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer
por: Wang, Minghui, et al.
Publicado: (2021)

Transcriptome and metabolome analyses of lignin biosynthesis mechanism of Platycladus orientalis
por: Li, Ying, et al.
Publicado: (2022)

Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma
por: Zhang, Si, et al.
Publicado: (2021)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development
por: Xu, Yan, et al.
Publicado: (2019)

A novel predicted model for hypertension based on a large cross-sectional study
por: Ren, Zhigang, et al.
Publicado: (2020)

Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study
por: Yang, Yarong, et al.
Publicado: (2021)

Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA
por: Wang, Yaqin, et al.
Publicado: (2021)

Metabolomics profiling reveals differences in proliferation between tumorigenic and non-tumorigenic Madin-Darby canine kidney (MDCK) cells
por: Sun, Na, et al.
Publicado: (2023)

Integrated transcriptome and metabolome analyses revealed regulatory mechanisms of flavonoid biosynthesis in Radix Ardisia
por: Liu, Chang, et al.
Publicado: (2022)

Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article
por: Huang, Ya, et al.
Publicado: (2015)

Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer
por: Wang, Hongbo, et al.
Publicado: (2023)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Mowry, Christopher J., et al.
Publicado: (2021)

Integrative study of Arabidopsis thaliana metabolomic and transcriptomic data with the interactive MarVis-Graph software
por: Landesfeind, Manuel, et al.
Publicado: (2014)

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
por: Yu, Yao, et al.
Publicado: (2018)

Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
por: Dong, Shu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eq6tde9ffbea2cuklc2c4s0a7m